Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$224.6K
4.47K shares
What this filing means
SENSENIG BETHANY plans to sell 4.47K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $224.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/19/2026ACC: 0001950047-26-001511
Director
Since Feb 2026
4.47K
Shares to sell
$224.6K
Approx. market value
4.47K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/19/2026
4.47KTotal acquired4.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/19/2026 | Restricted Stock Units N/A | 4.47K | — |
| Total | 4.47K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.47K
Market value
$224.6K
2/19/2026
Total
Units
4.47K
Value
$224.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/19/2026 | 4.47K | $224.6K | NASDAQ | Planned |
| Total | 4.47K | $224.6K | ||